These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7730906)
21. Stopping clinical trials early for benefit: impact on estimation. Freidlin B; Korn EL Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463 [TBL] [Abstract][Full Text] [Related]
22. Continuous and group sequential conditional probability ratio tests for phase II clinical trials. Tan M; Xiong X Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138 [TBL] [Abstract][Full Text] [Related]
23. Sequential tests for noninferiority and superiority. Brannath W; Bauer P; Maurer W; Posch M Biometrics; 2003 Mar; 59(1):106-14. PubMed ID: 12762447 [TBL] [Abstract][Full Text] [Related]
24. Early stopping to accept H(o) based on conditional power: approximations and comparisons. Betensky RA Biometrics; 1997 Sep; 53(3):794-806. PubMed ID: 9290216 [TBL] [Abstract][Full Text] [Related]
25. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M; J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993 [TBL] [Abstract][Full Text] [Related]
26. Interim analysis in clinical trials. Armitage P Stat Med; 1991 Jun; 10(6):925-35; discussion 936-7. PubMed ID: 1876782 [TBL] [Abstract][Full Text] [Related]
27. Choosing Interim Sample Sizes in Group Sequential Designs. Tarima S; Flournoy N Stud Health Technol Inform; 2021 May; 278():11-16. PubMed ID: 34042870 [TBL] [Abstract][Full Text] [Related]
28. Sequential clinical trials for normal variates using interval composite hypotheses. Lachin JM Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445 [TBL] [Abstract][Full Text] [Related]
29. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome. Zhao Y; Grambsch PM; Neaton JD Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513 [TBL] [Abstract][Full Text] [Related]
30. [Interim analysis in clinical trials: a methodological guide]. Muñoz Navarro SR; Bangdiwala SI Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556 [TBL] [Abstract][Full Text] [Related]
31. A stochastically curtailed two-arm randomised phase II trial design for binary outcomes. Law M; Grayling MJ; Mander AP Pharm Stat; 2021 Mar; 20(2):212-228. PubMed ID: 32860470 [TBL] [Abstract][Full Text] [Related]
32. A stochastically curtailed single-arm phase II trial design for binary outcomes. Law M; Grayling MJ; Mander AP J Biopharm Stat; 2022 Sep; 32(5):671-691. PubMed ID: 35077268 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. Tan M; Xiong X; Kutner MH Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648 [TBL] [Abstract][Full Text] [Related]
34. Interim analyses, stopping rules and data monitoring in clinical trials in Europe. Buyse M Stat Med; 1993 Mar; 12(5-6):509-20. PubMed ID: 8493429 [TBL] [Abstract][Full Text] [Related]
35. Information time scales for interim analyses of randomized clinical trials. Freidlin B; Othus M; Korn EL Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947 [TBL] [Abstract][Full Text] [Related]
36. Stochastic curtailment of health questionnaires: a method to reduce respondent burden. Finkelman MD; He Y; Kim W; Lai AM Stat Med; 2011 Jul; 30(16):1989-2004. PubMed ID: 21520454 [TBL] [Abstract][Full Text] [Related]